The research team members say they have long known that infections such as the flu can increase risk for heart disease and heart attack, but the sharp rise in heart attack deaths is like nothing seen before.
News | Coronavirus (COVID-19)
COVID-19 Surges Linked to Spike in Heart Attacks

October 27, 2022 — New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks ...

Home October 27, 2022
Home
Clinical study evaluates treatment for endovascular aortic arch repair
News | Endovascular Aortic Repair
UH Harrington Heart and Vascular Institute Performs First TRIOMPHE Study Case in Northeast Ohio

October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...

Home October 26, 2022
Home
Alex Carll, assistant professor in the UofL Department of Physiology, front, with Matthew Nystoriak, associate professor of medicine. (UofL Photo)
News | Atrial Fibrillation
UofL Researchers Discover E-Cigarettes Cause Cardiac Arrhythmias

October 26, 2022 — A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute ...

Home October 26, 2022
Home
Analysis of randomized controlled trial data shows non-Caucasian high-risk PCI patients significantly benefit from Impella-support
News | Intra-Aortic Balloon Pumps (IABP)
Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare

October 26, 2022 — Abiomed (Nasdaq: ABMD) announces a new program to address healthcare disparities in underserved ...

Home October 26, 2022
Home
Videos | TCT
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation

At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional ...

Home October 26, 2022
Home
CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
News | Holter Monitoring Systems
RhythMedix Expands Monitoring Capabilities of Its RhythmStar System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity

October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms ...

Home October 25, 2022
Home
Asher Kimchi, MD: 1946-2022
News | Cardiovascular Business
Founder, Medical Co-Director of Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute Remembered

October 24, 2022 — Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine ...

Home October 24, 2022
Home
CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
News | Hypertension
CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research

October 24, 2022 — CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly ...

Home October 24, 2022
Home
Donald Baril, MD, a Leading Vascular Surgeon in the Smidt Heart Institute, Named Director of the Vascular Surgery Fellowship Program
News | Cardiovascular Surgery
Vascular Surgeon to Lead, Train Fellows

October 24, 2022 The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as ...

Home October 24, 2022
Home
Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated announced submission of pivotal clinical data from the AcQForce Flutter trial
News
Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter and System

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps.
News | Cardiogenic Shock
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure

October 21, 2022 — Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post ...

Home October 21, 2022
Home
Medtronic “Conduction System Pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates
News | Catheter
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System

October 21, 2022 — Medtronic plc, a global leader in healthcare technology, today announced it has received U.S. Food ...

Home October 21, 2022
Home
A composite photo demonstrating how mixed reality visualization would be combined with robotic surgery in an MRI.
News | Robotic Systems
Mixed-Reality Robotic Heart Surgery Inside an MRI?

October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National ...

Home October 20, 2022
Home
The American Heart Association to enable a wide range of research with real-time data from acute care hospitals
News | Cardiogenic Shock
New Data Registry Collects Evidence in Cardiogenic Shock Patients

October 20, 2022 — Cardiogenic shock—a life threatening condition when a person’s heart can’t pump enough blood to meet ...

Home October 20, 2022
Home
MedAtlas CV will transform cardiovascular care delivery and expand patient access
News | Cardiovascular Business
Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV

October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers ...

Home October 20, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now